Anne Samuel
Stock Analyst at JP Morgan
(1.82)
# 3,306
Out of 5,149 analysts
67
Total ratings
50%
Success rate
-2.86%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $13 → $7 | $3.51 | +99.43% | 13 | Nov 17, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $125 → $126 | $80.43 | +56.66% | 9 | Sep 3, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $185.91 | +55.99% | 7 | Aug 28, 2025 | |
| PGNY Progyny | Maintains: Neutral | $23 → $25 | $17.52 | +42.69% | 8 | Aug 26, 2025 | |
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $26.97 | +122.47% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $173.96 | +1.75% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $40.80 | -11.76% | 5 | Mar 20, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $12.37 | +126.35% | 2 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $30.58 | -31.33% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $1.72 | +655.81% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $26.58 | +1.58% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $1.16 | +331.03% | 1 | Jul 31, 2024 |
Evolent Health
Nov 17, 2025
Maintains: Overweight
Price Target: $13 → $7
Current: $3.51
Upside: +99.43%
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $80.43
Upside: +56.66%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $185.91
Upside: +55.99%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $17.52
Upside: +42.69%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $26.97
Upside: +122.47%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $173.96
Upside: +1.75%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $40.80
Upside: -11.76%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $12.37
Upside: +126.35%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $30.58
Upside: -31.33%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $1.72
Upside: +655.81%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $26.58
Upside: +1.58%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $1.16
Upside: +331.03%